Ireland-based Perrigo plans to shed its prescription pharmaceutical unit, which accounts for about one-fifth of total revenue, allowing the company to focus on expanding its consumer business.
from WSJ.com: US Business https://ift.tt/2vOsrH8
via IFTTT
No comments:
Post a Comment